Español
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Lymphoma - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Monoclonal Antibody Therapy for Treatment-Resistant Blood Cancers
    (Posted: 03/29/2005, Updated: 05/16/2007) - This phase I dose-escalation study is investigating safety and tolerability of siplizumab, and will determine the maximum dose that can be given to patients with CD2-positive lymphoproliferative disease.
  • Romidepsin for T-Cell Lymphoma
    (Posted: 01/13/2004, Updated: 05/01/2007) - With this trial, researchers are seeking to determine whether romidepsin (depsipeptide, FR901228), a histone deacetylase inhibitor, can help bring about remission in patients with T-cell lymphoma.
  • Treating Adult T-cell Leukemia/Lymphoma
    (Posted: 11/07/2006) - In this clinical trial, researchers will use denileukin diftitox (Ontak), a genetically engineered protein that combines segments of interleukin-2 and diphtheria toxin, to treat patients with adult T cell leukemia/lymphoma that shows a receptor protein for interleukin-2.
  • Studying Chronic Graft-versus-Host Disease
    (Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it.
  • Targeted Therapy for Mantle Cell Lymphoma
    (Posted: 01/10/2006) - In this trial, researchers will treat mantle cell lymphoma patients with a drug called bortezomib, followed by induction therapy with bortezomib and a chemotherapy combination known as DA-EPOCH-R, along with the drug filgrastim to stimulate white blood cell production. Half of the patients will subsequently receive bortezomib maintenance therapy.
< Previous  1 2 3 4  Next >